Experimental virus therapy tested for Hard-to-Treat breast cancer
NCT ID NCT05376527
First seen May 04, 2026 · Last updated May 05, 2026 · Updated 2 times
Summary
This early-phase study tested a new drug made from a modified virus in 34 women with advanced breast cancer that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the highest dose that doesn't cause severe side effects. The drug was injected directly into tumors, first as a single dose and then weekly for four weeks. This is not a cure; it aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLYTIC VIROTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Moscow, Russia, 115478, Russia
-
N.N. Petrov National Medical Research Center of Oncology
Saint Petersburg, Russia, 197758, Russia
-
National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation
Obninsk, Russia, 249036, Russia
-
Oncology Research Center, LLC
Saint Petersburg, Russia, 197758, Russia
Conditions
Explore the condition pages connected to this study.